Head-to-head · WeighScore
Lttl vs No BS RX
By GLP-1 ScorecardUpdated
Score comparison
No BS RX has the higher recorded score — 82.8/100 to 63.5/100.
No BS RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Twenty-four prices on one public page, four dispensing pharmacies named with street addresses, and a no-intro-rate promise the arithmetic actually supports.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Lttl | No BS RX |
|---|---|---|
| WeighScore | 63.5/100 | 82.8/100 |
| Grade | C | B− |
| Site position | #210 | #25 |
| Semaglutide | $99/mo monthly auto-refill; $89/mo equivalent billed $1,068 annually (confirm supply/renewal) | $179/mo month-to-month (a separate low-dose program is $140) |
| Tirzepatide | $149/mo monthly auto-refill; $139/mo equivalent billed $1,668 annually (confirm supply/renewal) | $249/mo month-to-month (a separate low-dose program is $140) |
| Coverage | Provider claims 50 states + DC; treatment availability varies | Not publicly listed |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #210 · C
Strengths
- Public ordinary monthly injection rates of $99 semaglutide and $149 tirzepatide, with longer-plan charges disclosed separately
- The plan selector identifies supply lengths, including four weeks for monthly auto-refill and 52 weeks annually
- Four possible dispensing pharmacies are named in the terms, without an individual assignment established
- Microdose injection and oral-tablet selector entries provide additional options to discuss with a clinician; availability and clinical suitability require confirmation
What to consider
- Monthly, quarterly and six-month supply labels do not align with calendar-month language; confirm actual refill and debit intervals
- Medical-rejection refund language conflicts with consultation-fee retention wording
- Terms use medical intake as a nonrefund boundary, while support uses pharmacy processing/shipping; refund deadlines also differ
- The assigned treating practice, prescriber and actual dispensing location remain unestablished
- Branded-service exceptions are described, but no available brand-specific prescription or price was established
- A 48-hour shipping headline differs from the policy estimate of two to five business days processing plus three to seven in transit
Site position #25 · B−
Strengths
- Names four dispensing pharmacies with street addresses and telephone numbers — Red Rock Compounding Pharmacy, Health Warehouse, Precision Medicine and Triad Rx
- "No Fake Intro Rate — the price on the page is the ongoing program price" is a named commitment, and the $140 in its hero really is a month-to-month rate on a real product
- Every program row prints "503A pharmacy fulfillment" and "No dose-based price changes" on the table itself
- Six programs across four terms are published with no intake and no account
- A sleep program is priced on the same page, including a diagnostic ring study at $33/mo
What to consider
- The same $409 twelve-week block appears under three different monthly rates — an $11 saving against one and a $128 saving against another, styled identically
- The low-dose programs stop at twelve weeks; only the standard programs carry 24- and 52-week rungs
- The Terms name four pharmacies and no operating company
- State availability is not published, and there is no FDA-approved brand lane
Featured provider
Lttl
Lttl scores 63.5/100 (C). Lttl publishes monthly and longer compounded-injection offers plus a low-dose and oral menu; compare the actual charge and supply interval because annual equivalents and four-week labels describe different commitments.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.